Applied Therapeutics Welcomes Dale Hooks as New CCO
PremiumCompany AnnouncementsApplied Therapeutics Welcomes Dale Hooks as New CCO
3M ago
Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
PremiumPress Releases
Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
3M ago
Applied Therapeutics appoints Dale Hooks as CCO
PremiumThe Fly
Applied Therapeutics appoints Dale Hooks as CCO
3M ago
Applied Therapeutics initiated with an Outperform at RBC Capital
PremiumThe FlyApplied Therapeutics initiated with an Outperform at RBC Capital
4M ago
Applied Therapeutics files to sell 14.29M shares of common stock for holders
PremiumThe Fly
Applied Therapeutics files to sell 14.29M shares of common stock for holders
4M ago
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
4M ago
Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results
PremiumPress ReleasesApplied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results
5M ago
Applied Therapeutics to sell 12.3M shares at $7.00 in private placement
PremiumThe Fly
Applied Therapeutics to sell 12.3M shares at $7.00 in private placement
5M ago
Applied Therapeutics Announces $100 Million Private Placement
PremiumPress Releases
Applied Therapeutics Announces $100 Million Private Placement
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100